Medications

Cost of epilepsy meds continues to soar

Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research.

Neuroscience

Cost-effectiveness of treatments in neurological diseases

Professor Dyfrig Hughes and colleagues at the Center for Health Economics and Medicines Evaluation, School of Health Sciences, have recently published the results of three clinical trials of interventions in epilepsy and ...

Medications

Antiepileptic drugs not tied to dementia risk

(HealthDay)—Antiepileptic drug (AED) use is not significantly associated with dementia risk in patients in Germany, according to a study published online March 12 in the Journal of Alzheimer's Disease.

Alzheimer's disease & dementia

No association between antiepileptic drug use and dementia

Epilepsy is a common neurological condition with a prevalence of around 2%. Many antiepileptic drugs are available to prevent epileptic seizures, allowing up to 80 percent of patients to become seizure-free. However, previous ...

page 2 from 9